rs11247226
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001040616.3(LINS1):āc.85A>Gā(p.Ile29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.436 in 1,608,252 control chromosomes in the GnomAD database, including 158,490 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001040616.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LINS1 | NM_001040616.3 | c.85A>G | p.Ile29Val | missense_variant | 2/7 | ENST00000314742.13 | NP_001035706.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINS1 | ENST00000314742.13 | c.85A>G | p.Ile29Val | missense_variant | 2/7 | 5 | NM_001040616.3 | ENSP00000318423 | P1 |
Frequencies
GnomAD3 genomes AF: 0.363 AC: 55183AN: 151904Hom.: 11064 Cov.: 32
GnomAD3 exomes AF: 0.374 AC: 93282AN: 249322Hom.: 19138 AF XY: 0.388 AC XY: 52254AN XY: 134758
GnomAD4 exome AF: 0.443 AC: 645435AN: 1456230Hom.: 147425 Cov.: 37 AF XY: 0.444 AC XY: 320851AN XY: 723264
GnomAD4 genome AF: 0.363 AC: 55200AN: 152022Hom.: 11065 Cov.: 32 AF XY: 0.360 AC XY: 26738AN XY: 74320
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at